Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen

Baldew, 1990, Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen, Cancer Res., 50, 7031 Bleiberg, 1990, Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus5-FU in advanced colorectal carcinoma. An ORTC Gastrointestinal Tract Cancer Cooperative Group study, Cancer Invest., 8, 471, 10.3109/07357909009012070 Cassandro, 2003, Effect of superoxide dismutase and allopurinol on impulse noise-exposed guinea pigs – electrophysiological and biochemical study, Acta Otolaryngol., 123, 802, 10.1080/00016480300683 De Besi, 1988, Systemic chemotherapy with cisplatin, 5-fluorouracil and allopurinol in the management of advanced epidermoid esophageal cancer, Recent Results Cancer Res., 110, 196, 10.1007/978-3-642-83293-2_30 Erdinc, 2000, Potentiation of cisplatin-induced nephrotoxicity in rats by allopurinol, Exp. Toxicol. Pathol., 52, 329, 10.1016/S0940-2993(00)80058-5 Fischer, 1988, A novel biologically active seleno-organic compound. VIII. Biotransformation of ebselen, Xenobiotica, 18, 1347, 10.3109/00498258809042259 Hatzopoulos, 1999, Evaluation of cisplatin ototoxicity in a rat animal model, Ann. N. Y. Acad. Sci., 884, 211, 10.1111/j.1749-6632.1999.tb08643.x Hensley, 1999, American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants, J. Clin. Oncol., 17, 3333, 10.1200/JCO.1999.17.10.3333 Hinojosa, 1995, Temporal bone histopathology of cisplatin ototoxicity, Am. J. Otol., 16, 731 Huang, 2000, Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies, Int. J. Dev. Neurosci., 18, 259, 10.1016/S0736-5748(99)00094-5 Husain, 1998, Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system, Mol. Cell. Biochem., 178, 127, 10.1023/A:1006889427520 Kopke, 1997, Use of organotypic cultures of Corti’s organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells, Am. J. Otol., 18, 559 Laurell, 1991, Degeneration of the organ of Corti following intravenous administration of cisplatin, Acta Otolaryngol., 111, 891, 10.3109/00016489109138427 Lautermann, 1997, Glutathione-dependent antioxidant systems in the mammalian inner ear: effects of aging, ototoxic drugs and noise, Hear Res., 114, 75, 10.1016/S0378-5955(97)00154-8 Lee, 1987, Phase II pilot study with cisplatin, etoposide, and continuous-infusion 5-fluorouracil in metastatic non-small cell lung cancer, Am. J. Clin. Oncol., 10, 512, 10.1097/00000421-198712000-00010 Lynch, 2004, Ebselen-mediated protection from single and repeated noise exposure in rat, Laryngoscope, 114, 333, 10.1097/00005537-200402000-00029 McFadden, 2001, The influence of superoxide dismutase and glutathione peroxidase deficiencies on noise-induced hearing loss in mice, Noise Health, 3, 49 Melamed, 2000, Cisplatin-induced increases in spontaneous neural activity in the dorsal cochlear nucleus and associated outer hair cell loss, Audiology, 39, 24, 10.3109/00206090009073051 Moroso, 1983, A review of cisplatinum ototoxicity, J. Otolaryngol., 12, 365 Ogawa, 1999, Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial, Cerebrovasc. Dis., 9, 112, 10.1159/000015908 Ohlemiller, 2000, Targeted mutation of the gene for cellular glutathione peroxidase (Gpx1) increases noise-induced hearing loss in mice, J. Assoc. Res. Otolaryngol., 1, 243, 10.1007/s101620010043 Pourbakht, 2003, Ebselen attenuates cochlear damage caused by acoustic trauma, Hear Res., 181, 100, 10.1016/S0378-5955(03)00178-3 Ravi, 1995, Mechanism of cisplatin ototoxicity: antioxidant system, Pharmacol. Toxicol., 76, 386, 10.1111/j.1600-0773.1995.tb00167.x Rybak, 1999, Ototoxicity amelioration by protective agents, Ann. N. Y. Acad. Sci., 884, 143 Rybak, 2000, Effect of protective agents against cisplatin ototoxicity, Am. J. Otol., 21, 513 Saito, 1994, Comparative ototoxicity of cisplatin during acute and chronic treatment, ORL J. Otorhinolaryngol. Relat. Spectrosc., 56, 315, 10.1159/000276683 Seidman, 1993, The protective effects of allopurinol and superoxide dismutase on noise-induced cochlear damage, Otolaryngol. Head Neck Surg., 109, 1052, 10.1177/019459989310900613 Song, 1996, Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo, Hear Res., 94, 87, 10.1016/0378-5955(96)00003-2 Stadnicki, 1975, cis-Dichlorodiammineplatinum(II) (NSC-119875): hearing loss and other toxic effects in rhesus monkeys, Cancer Chemother. Rep., 59, 467 Tange, 1984, Changes in the stria vascularis of the guinea pig due to cis-platinum, Arch. Otorhinolaryngol., 239, 41, 10.1007/BF00454261 Weiss, 1990, A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial, Gynecol. Oncol., 37, 354, 10.1016/0090-8258(90)90366-S Yamaguchi, 1998, Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group, Stroke, 29, 12, 10.1161/01.STR.29.1.12 Yoshida, 2000, Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats, Tohoku J. Exp. Med., 191, 209, 10.1620/tjem.191.209